Uzbekistan's National Payment System HUMO and Ant International’s Alipay+ Partner to Facilitate Cross-Border QR Payments
28.10.2025 07:55:00 EET | Business Wire | Press release
Alipay+, Ant International’s global wallet gateway, and HUMO, the national payment system in Uzbekistan, announced the partnership in Beijing to facilitate inbound and outbound cross-border QR payments. The Octomobile app by Octobank will be the first Uzbek e-wallet integrated with Alipay+, with more HUMO-connected local e-wallets and bank apps expected to join by the end of the year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027737149/en/
The delegation from HUMO and Octomobile experienced Alipay+ payments at Beijing's Wukesong Wanda Plaza
HUMO has become the tenth national QR code network to partner with Alipay+. In the initial phase, HUMO users from Uzbekistan will be able to travel in China and over 50 other countries—including Kazakhstan, Thailand, UAE, United States and beyond—effortlessly for payments in Uzbek som through their preferred home payment methods / banking apps, across their travel experience, including retail, dining and transportation.
Alipay+ now partners with 40 e-wallets and bank apps and 10 national QR payment schemes and payment systems worldwide, connecting over 100 million merchants to 1.8 billion consumers accounts. Leveraging this extensive connectivity, Uzbek merchants can now seamlessly accept payments from users of Alipay+ connected wallets and apps worldwide—creating new global opportunities and driving growth at scale.
In China, Ant International has established itself as the largest inbound payment facilitator in terms of coverage, use cases, and business volume, backed by a leading-scale ecosystem that supports 7 international card brands and 31 e-wallets from 12 countries and regions. Kaspi, Kazakhstan's largest e-wallet, is also accepted in China, joining HUMO from Uzbekistan in a growing payments interoperability from Central Asia.
Alipay+ began as a cross-border payment technology solution dedicated to advancing global connectivity. Today, through collaboration with global e-wallet partners and the application of AI payments, marketing and digitalization technologies, it is catalysing the development of new travel habits, enhancing payment security, and promoting inclusive economic growth.
As travellers increasingly rely on technology to enhance their journeys, Alipay+ has launched Alipay+ Voyager, an AI travel agent integrated into digital wallets. This always-on service enhances travel experiences for users while helping partner wallets engage travellers with personalized interactions.
With digital wallets becoming preferred payment methods globally, Alipay+ is reinforcing its commitment to secure transactions through the newly launched "Digital Wallet Guardian Partnership". Under this initiative, partner wallets will adopt the Alipay+ EasySafePay 360 solution, an AI-powered protection system that uses real-time analysis and privacy computing to reduce account takeover risks by up to 90% while safeguarding user privacy. AlipayHK and TNG eWallet are the pilot partners in this program.
Maksad Mukhitdinov, First Deputy to Chairman of the Board, HUMO said:" We are glad to partner with Ant International's Alipay+ in this milestone collaboration. This partnership not only enables seamless global travel for Uzbek users but also creates tangible growth opportunities for businesses. As an integral part of Uzbekistan's payment system, HUMO is connected to 35 local banks and 42 non-bank financial institutions. We look forward to achieving more with Alipay+."
Edward Yue, Alipay+ General Manager for SEA, ANZ and South Asia, Ant International said: “We are delighted to partner with HUMO, expanding Alipay+’s reach across Central Asia to over 45 million digital wallet users. The payment link will enhance the travel experience for Uzbek tourists with easy payments, attractive offers, and digital services. It will also help local merchants welcome international tourists and boost Uzbekistan's tourism economy.”
About Alipay+
Ant International's Alipay+ is a global wallet gateway with cross-border payment and digitisation services that help connect global merchants to consumers. Consumers enjoy seamless payments a broad choice of deals and the convenience of digital services using their preferred payment app/e-wallet while travelling abroad. Many small and medium-sized businesses already use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251027737149/en/
Contacts
Media Contact:
Xiaoyi Wang
cynthia.wxy@ant-intl.com
Ant International PR
pr@ant-intl.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences23.9.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology (EADV) Congress. Through these activities, Galderma will showcase how it continues to advance its pipeline and the science of dermatology, deepening understanding of biological and quality-of-life factors, while driving innovation in targeted treatments, skin longevity and evidence-based care. “At Galderma, we recognize that advancing dermatology means not only addressing the needs of patients living with common chronic skin conditions, such as atopic dermatitis and acne, but also anticipating the trends that will shape the future of skin health. Our presence at EADV demonstrates our unique ability to achieve this, with new data spanning both established areas of unmet need and emerging fields such as skin longevity, helping drive innovation and meaningful outcomes for patients today and i
Oticon Medical Launches SmartCharger for the Ponto 5 Family23.9.2026 08:00:00 EEST | Press release
Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922863462/en/ Oticon Medical today announces the launch of SmartCharger for the Ponto 5 family, introducing its first rechargeable solution for percutaneous sound processors and marking a new step in convenience and portability for bone anchored hearing system users. Powering the Ponto 5 family The launch of SmartCharger underlines Oticon Medical’s continued commitment to the Ponto family, which includes Ponto 5 SuperPower, the world’s most powerful abutment-level sound processor,1 and Ponto 5 Mini, the world’s smallest percutaneous sound processor.1 By bringing rechargeable convenience to the Ponto sound processors, Oticon Me
Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone
OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release
OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom